Skip to main content
California Medicine logoLink to California Medicine
. 1969 Mar;110(3):224–227.

Viremia in a Recipient of HPV-77 Rubella Virus Vaccine

Jeanette Wilkins, Margaret A Salvatore, John M Leedom, Bernard Portnoy
PMCID: PMC1503454  PMID: 5773481

Abstract

A live rubella virus vaccine, HPV-77 (High Passage Virus - 77 tissue culture passages) was administered subcutaneously to eight rubella-susceptible children housed in an isolation ward. One blood specimen, taken on the tenth day after vaccination, from one of the eight vaccines, yielded a rubella virus. This virus had laboratory markers which were “vaccine-like.” To our knowledge, this represents the first isolation of rubella virus from the blood of a recipient of HPV-77 vaccine. However, the consistent antibody responses among vaccinees and the regular presence of rubella virus in their pharynges argue that viremia occurs in almost every susceptible recipient. The most logical explanation for the failure to document viremia in other recipients of HPV-77 vaccine is that the viremia is ordinarily low grade or transient or both.

Full text

PDF
224

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. MCCARTHY K., TAYLOR-ROBINSON C. H., PILLINGER S. E. ISOLATION OF RUBELLA VIRUS FROM CASES IN BRITAIN. Lancet. 1963 Sep 21;2(7308):593–598. doi: 10.1016/s0140-6736(63)90393-3. [DOI] [PubMed] [Google Scholar]
  2. Meyer H. M., Jr, Parkman P. D., Panos T. C. Attenuated rubella virus. II. Production of an experimental live-virus vaccine and clinical trial. N Engl J Med. 1966 Sep 15;275(11):575–580. doi: 10.1056/NEJM196609152751102. [DOI] [PubMed] [Google Scholar]
  3. PARKMAN P. D., BUESCHER E. L., ARTENSTEIN M. S. Recovery of rubella virus from army recruits. Proc Soc Exp Biol Med. 1962 Oct;111:225–230. doi: 10.3181/00379727-111-27750. [DOI] [PubMed] [Google Scholar]
  4. PARKMAN P. D., MUNDON F. K., MCCOWN J. M., BUESCHER E. L. STUDIES OF RUBELLA. II. NEUTRALIZATION OF THE VIRUS. J Immunol. 1964 Oct;93:608–617. [PubMed] [Google Scholar]
  5. Parkman P. D., Meyer H. M., Jr, Kirschstein R. L., Hopps H. E. Attenuated rubella virus. I. Development and laboratory characterization. N Engl J Med. 1966 Sep 15;275(11):569–574. doi: 10.1056/NEJM196609152751101. [DOI] [PubMed] [Google Scholar]
  6. Parkman P. D., Phillips P. E., Kirschstein R. L., Meyer H. M., Jr Experimental rubella virus infection in the rhesus monkey. J Immunol. 1965 Oct;95(4):743–752. [PubMed] [Google Scholar]
  7. Stewart G. L., Parkman P. D., Hopps H. E., Douglas R. D., Hamilton J. P., Meyer H. M., Jr Rubella-virus hemagglutination-inhibition test. N Engl J Med. 1967 Mar 9;276(10):554–557. doi: 10.1056/NEJM196703092761006. [DOI] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES